Ameritas Investment Partners, Inc. - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 103 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,416
-62.0%
1,3500.0%0.00%
Q2 2023$8,991
-64.3%
1,3500.0%0.00%
-100.0%
Q1 2023$25,191
-39.8%
1,3500.0%0.00%
-50.0%
Q4 2022$41,823
+178.8%
1,3500.0%0.00%
+100.0%
Q3 2022$15,000
-11.8%
1,3500.0%0.00%0.0%
Q2 2022$17,000
-39.3%
1,3500.0%0.00%0.0%
Q1 2022$28,000
+3.7%
1,3500.0%0.00%0.0%
Q4 2021$27,000
-18.2%
1,350
+25.0%
0.00%0.0%
Q3 2021$33,000
+6.5%
1,0800.0%0.00%0.0%
Q2 2021$31,000
-34.0%
1,0800.0%0.00%
-50.0%
Q1 2021$47,000
+9.3%
1,080
+15.5%
0.00%0.0%
Q4 2020$43,000
+4.9%
9350.0%0.00%0.0%
Q3 2020$41,000
-18.0%
9350.0%0.00%0.0%
Q2 2020$50,000
+316.7%
935
+76.1%
0.00%
+100.0%
Q1 2020$12,000
+50.0%
5310.0%0.00%
Q4 2019$8,000
+100.0%
5310.0%0.00%
Q3 2019$4,000
-33.3%
5310.0%0.00%
Q2 2019$6,0005310.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 40,000$836,0001.01%
ACT CAPITAL MANAGEMENT, LLC 20,000$418,0000.44%
Knoll Capital Management, LLC 20,000$418,0000.26%
Artemis Investment Management LLP 1,428,228$29,855,0000.24%
Rubric Capital Management LP 268,528$5,615,0000.20%
Virtus ETF Advisers LLC 7,713$161,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 107,700$2,252,0000.05%
PDT Partners, LLC 28,031$586,0000.05%
AllSquare Wealth Management LLC 3,162$66,0000.04%
Hennion & Walsh Asset Management, Inc. 35,221$736,0000.04%
View complete list of BIOXCEL THERAPEUTICS INC shareholders